A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
Plans whose provider directory lists this clinician
Licensed to practise in California · since 1994 · expires 2028-09-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$5,222
Medicare paid this office $5,222 for 45 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Short return visit (20+ min)
11
$991
$76
Cervical or vaginal cancer screening; pelvic and clinical breast examination
17
$818
$48
Who their Medicare patients are
45 Original Medicare patients in 2024. Average age 75 · Women 100% · Health risk score 0.82. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 49%.
The office billed $21,329, Medicare allowed $6,760 and paid $5,222; for 65 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
45
65
75
0.82
$21,329
$5,222
2023
40
54
73
0.53
$20,098
$5,293
2022
37
44
72
0.56
$9,935
$2,723
2021
48
86
73
0.69
$26,536
$7,251
2020
39
74
71
0.78
$24,502
$6,100
2019
61
93
71
0.74
$23,180
$5,983
2018
58
84
74
0.76
$26,446
$6,073
2017
60
100
71
0.77
$25,944
$6,707
2016
45
73
70
0.93
$29,577
$7,486
2015
71
128
70
0.93
$38,639
$10,485
2014
53
76
69
0.91
$23,595
$6,419
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
Original Medicare services billed in 2023
Short return visit (20+ min)
11
$890
$74
Cervical or vaginal cancer screening; pelvic and clinical breast examination
12
$587
$49
2022: 1 service
Original Medicare services billed in 2022
Cervical or vaginal cancer screening; pelvic and clinical breast examination
14
$676
$48
2021: 3 services
Original Medicare services billed in 2021
Short return visit (20+ min)
14
$1,237
$77
Cervical or vaginal cancer screening; pelvic and clinical breast examination
16
$784
$49
Short return visit
12
$736
$53
2020: 1 service
Original Medicare services billed in 2020
Cervical or vaginal cancer screening; pelvic and clinical breast examination
11
$539
$49
2019: 4 services
Original Medicare services billed in 2019
New patient visit (15+ min)
14
$881
$63
Cervical or vaginal cancer screening; pelvic and clinical breast examination
18
$854
$47
Short return visit (20+ min)
14
$820
$59
Short return visit
11
$627
$39
2018: 1 service
Original Medicare services billed in 2018
Cervical or vaginal cancer screening; pelvic and clinical breast examination
22
$1,003
$46
2017: 1 service
Original Medicare services billed in 2017
Short return visit (20+ min)
20
$1,592
$69
2016: 1 service
Original Medicare services billed in 2016
Cervical or vaginal cancer screening; pelvic and clinical breast examination
14
$634
$45
2015: 3 services
Original Medicare services billed in 2015
Short return visit (20+ min)
27
$2,051
$57
Cervical or vaginal cancer screening; pelvic and clinical breast examination
22
$1,047
$48
Short return visit
14
$617
$39
2014: 1 service
Original Medicare services billed in 2014
Cervical or vaginal cancer screening; pelvic and clinical breast examination
18
$809
$45
Drugs they prescribed that Part D paid
$9,367
Pharmacies billed $9,367 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 79) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
58 generic and 21 brand-name prescriptions · $9,367 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Estradiol
12
$1,026
$49
Year by year
Part D prescribing by year
2024
79
30
0% (0)
27%
$9,367
2023
70
23
—None
24%
$11,794
2022
59
20
0% (0)
25%
$8,883
2021
51
18
0% (0)
39%
$10,806
2020
62
21
—None
35%
$12,925
2019
71
24
0% (0)
30%
$11,166
2018
91
29
0% (0)
36%
$16,625
2017
112
29
0% (0)
50%
$18,200
2016
141
31
—None
50%
$16,561
2015
126
35
—None
55%
$17,888
2014
102
26
0% (0)
73%
$12,984
2013
82
26
—None
50%
$9,435
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
Part D drugs prescribed in 2023
Estradiol
20
$1,725
$86
2022: 1 drug
Part D drugs prescribed in 2022
Estradiol
12
$1,154
$96
2020: 1 drug
Part D drugs prescribed in 2020
Estradiol
17
$2,979
$175
2019: 1 drug
Part D drugs prescribed in 2019
Estradiol
24
$4,988
$208
2018: 2 drugs
Part D drugs prescribed in 2018
Estradiol
28
$5,707
$204
Premarin
11
$5,205
$473
2017: 4 drugs
Part D drugs prescribed in 2017
Estrace
17
$4,875
$287
Vagifem
18
$4,144
$230
Estradiol
14
$2,030
$145
Oxybutynin Chloride
14
$356
$25
2016: 3 drugs
Part D drugs prescribed in 2016
Vagifem
27
$5,768
$214
Premarin
14
$4,508
$322
Estradiol
36
$2,007
$56
2015: 4 drugs
Part D drugs prescribed in 2015
Premarin
25
$7,823
$313
Estrace
12
$2,747
$229
Vagifem
16
$2,626
$164
Estradiol
17
$1,307
$77
2014: 5 drugs
Part D drugs prescribed in 2014
Premarin
17
$4,149
$244
Vagifem
22
$2,921
$133
Estrace
12
$1,887
$157
Vivelle-Dot
14
$1,664
$119
Estradiol
13
$653
$50
2013: 3 drugs
Part D drugs prescribed in 2013
Estrace
18
$2,506
$139
Vivelle-Dot
11
$1,608
$146
Vagifem
15
$1,158
$77
Professional record
NPI
1003904350
Licence
CA G80084California G80084: Current · expires 2028-09-30
Trained
University of California, San Francisco School of Medicine, 1993